RXRX logo

RXRX EV/EBITDA

Current (TTM)-3.32×
RXRX Quarterly EV/EBITDA (-180.36× → -13.07×)
High-resolution chart · PNG

RXRX ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Recursion Pharmaceuticals Inc Clas EV/EBITDA — Quarterly
Period endingEV/EBITDA
-13.0661×
-10.2157×
-16.8008×
-11.3581×
-11.3284×
-9.426×
-10.8002×
-17.3468×
-16.035×
-23.1603×
-21.8827×
-15.264×
-16.1838×
-13.9331×
-17.1861×
-25.1189×
-15.9595×
-14.4058×
-41.8976×
-78.1132×
-143.387×
-97.4066×
-115.4509×
0×
0×
-180.3594×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.